171 related articles for article (PubMed ID: 15749835)
1. Identification and characterization of the Hesr1/Hey1 as a candidate trans-acting factor on gene expression through the 3' non-coding polymorphic region of the human dopamine transporter (DAT1) gene.
Fuke S; Sasagawa N; Ishiura S
J Biochem; 2005 Feb; 137(2):205-16. PubMed ID: 15749835
[TBL] [Abstract][Full Text] [Related]
2. Hesr1 knockout mice exhibit behavioral alterations through the dopaminergic nervous system.
Fuke S; Minami N; Kokubo H; Yoshikawa A; Yasumatsu H; Sasagawa N; Saga Y; Tsukahara T; Ishiura S
J Neurosci Res; 2006 Nov; 84(7):1555-63. PubMed ID: 16998899
[TBL] [Abstract][Full Text] [Related]
3. The androgen receptor facilitates inhibition of human dopamine transporter (DAT1) reporter gene expression by HESR1 and HESR2 via the variable number of tandem repeats.
Kanno K; Ishiura S
Neurosci Lett; 2012 Sep; 525(1):54-9. PubMed ID: 22819977
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of the HESR/HEY transcription factor family on dopamine transporter reporter gene expression via variable number of tandem repeats.
Kanno K; Ishiura S
J Neurosci Res; 2011 Apr; 89(4):562-75. PubMed ID: 21290414
[TBL] [Abstract][Full Text] [Related]
5. Association study of dopamine transporter gene and schizophrenia in Korean population using multiple single nucleotide polymorphism markers.
Jeong SH; Joo EJ; Ahn YM; Kim YS
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):975-83. PubMed ID: 15380858
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphism of the 3' VNTR region of the human dopaminergic function gene DAT1 (human dopamine transporter gene) in the Mongolian population.
Nakatome M; Honda K; Tun Z; Kato Y; Harihara S; Omoto K; Misawa S; Gerelsaikhan T; Nyamkhishig S; Dashnyam B; Batsuuri J; Wakasugi C
Hum Biol; 1996 Aug; 68(4):509-15. PubMed ID: 8754257
[TBL] [Abstract][Full Text] [Related]
7. [Lack of association between VNTR polymorphism of DAT gene and schizophrenia].
Hauser J; Kapelski P; Czerski PM; Godlewski S; Dmitrzak-Weglarz M; Twardowska K; Rybakowski JK
Psychiatr Pol; 2002; 36(3):403-12. PubMed ID: 12149916
[TBL] [Abstract][Full Text] [Related]
8. Identification of BOIP, a novel cDNA highly expressed during spermatogenesis that encodes a protein interacting with the orange domain of the hairy-related transcription factor HRT1/Hey1 in Xenopus and mouse.
Van Wayenbergh R; Taelman V; Pichon B; Fischer A; Kricha S; Gessler M; Christophe D; Bellefroid EJ
Dev Dyn; 2003 Dec; 228(4):716-25. PubMed ID: 14648848
[TBL] [Abstract][Full Text] [Related]
9. Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR.
Mill J; Asherson P; Browes C; D'Souza U; Craig I
Am J Med Genet; 2002 Dec; 114(8):975-9. PubMed ID: 12457396
[TBL] [Abstract][Full Text] [Related]
10. Sp1 and Sp3 activate transcription of the human dopamine transporter gene.
Wang J; Bannon MJ
J Neurochem; 2005 Apr; 93(2):474-82. PubMed ID: 15816870
[TBL] [Abstract][Full Text] [Related]
11. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression.
Fuke S; Suo S; Takahashi N; Koike H; Sasagawa N; Ishiura S
Pharmacogenomics J; 2001; 1(2):152-6. PubMed ID: 11911442
[TBL] [Abstract][Full Text] [Related]
12. Association of the risk allele of dopamine transporter gene (DAT1*10) in Omani male children with attention-deficit hyperactivity disorder.
Simsek M; Al-Sharbati M; Al-Adawi S; Ganguly SS; Lawatia K
Clin Biochem; 2005 Aug; 38(8):739-42. PubMed ID: 15993876
[TBL] [Abstract][Full Text] [Related]
13. Smoking status and the human dopamine transporter variable number of tandem repeats (VNTR) polymorphism: failure to replicate and finding that never-smokers may be different.
Vandenbergh DJ; Bennett CJ; Grant MD; Strasser AA; O'Connor R; Stauffer RL; Vogler GP; Kozlowski LT
Nicotine Tob Res; 2002 Aug; 4(3):333-40. PubMed ID: 12215242
[TBL] [Abstract][Full Text] [Related]
14. [Association between dopamine transporter gene polymorphism and Parkinson's disease].
Zhang L; Shao M; Xu Q; Dong X; Yang J; Li Y; Chen B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Dec; 18(6):431-4. PubMed ID: 11774209
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of transcription factor HESR1 on retinal vasculature.
Li B; Tang SB; Hu J; Gao Y; Zhang G; Lin SF; Chen JH; Li BJ
Microvasc Res; 2006 Nov; 72(3):146-52. PubMed ID: 17028039
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the human and mouse HEY1, HEY2, and HEYL genes: cloning, mapping, and mutation screening of a new bHLH gene family.
Steidl C; Leimeister C; Klamt B; Maier M; Nanda I; Dixon M; Clarke R; Schmid M; Gessler M
Genomics; 2000 Jun; 66(2):195-203. PubMed ID: 10860664
[TBL] [Abstract][Full Text] [Related]
17. Dopamine transporter gene polymorphism and alcoholism.
Muramatsu T; Higuchi S
Biochem Biophys Res Commun; 1995 Jun; 211(1):28-32. PubMed ID: 7779096
[TBL] [Abstract][Full Text] [Related]
18. Intronic sequences are involved in neural targeting of human dopamine transporter gene expression.
Kouzmenko AP; Pereira AM; Singh BS
Biochem Biophys Res Commun; 1997 Nov; 240(3):807-11. PubMed ID: 9398650
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine inhibition of angiogenesis involves the transcription factor HESR1.
Shah G; Middleton FA; Gentile KL; Tripathi S; Bruch D; Maier KG; Kittur DS
J Surg Res; 2008 Oct; 149(2):171-6. PubMed ID: 18694572
[TBL] [Abstract][Full Text] [Related]
20. Transient expression analysis of allelic variants of a VNTR in the dopamine transporter gene (DAT1).
Mill J; Asherson P; Craig I; D'Souza UM
BMC Genet; 2005 Jan; 6():3. PubMed ID: 15683546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
